Jpmorgan Chase & CO Pro Mis Neurosciences Inc. Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Pro Mis Neurosciences Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 253 shares of PMN stock, worth $452. This represents 0.0% of its overall portfolio holdings.
Number of Shares
253
Previous 388
34.79%
Holding current value
$452
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding PMN
# of Institutions
17Shares Held
3.38MCall Options Held
0Put Options Held
0-
Sphera Funds Management Ltd. Tel Aviv, L31.83MShares$3.28 Million0.55% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY1.06MShares$1.9 Million1.78% of portfolio
-
Affinity Asset Advisors, LLC New York, NY266KShares$476,0640.07% of portfolio
-
Northeast Financial Consultants Inc Westport, CT100KShares$179,0000.01% of portfolio
-
Bank Of Montreal Toronto, A630.4KShares$54,3550.0% of portfolio
About ProMIS Neurosciences Inc.
- Ticker PMN
- Exchange OTC
- Description
- ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms t...